Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Several countries include medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, a rare autosomal recessive disease, in their newborn screening programmes despite prevalence uncertainty. We estimated the frequency of its most common mutation, c.985A>G, tested for regional differences and compared screening and genotype frequencies. We identified 43 studies reporting the frequency of c.985A>G over 10 million individuals, and pooled frequency data using a novel Bayesian approach. We found significant variation in the frequency of the mutation across regions supporting a reported founder effect. The proportion of c.985A>G homozygotes was highest in Western Europe with 4.1 (95%CI: 2.8-5.6) per 100,000 individuals, then the New World (3.2, 95%CI: 2.0-4.7), Southern (1.2, 95%CI: 0.6-2.0) and Eastern European regions (0.9, 95%CI: 0.5-1.7). No cases with the mutation were identified in Asian and Middle Eastern regions. Significant differences were found in some countries between the genotype and screening allele frequency of c.985A>G. Our predictions could inform the frequency of the mutation by region and our approach could apply to other genetic conditions.

Original publication

DOI

10.1111/cge.12157

Type

Journal article

Journal

Clin Genet

Publication Date

03/2014

Volume

85

Pages

253 - 259

Keywords

MCAD deficiency, c.985A>G, inborn errors of metabolism, medium-chain acyl-CoA dehydrogenase deficiency, Acyl-CoA Dehydrogenase, Alleles, Europe, Gene Frequency, Genetic Heterogeneity, Genetic Testing, Genotype, Genotyping Techniques, Homozygote, Humans, Infant, Newborn, Lipid Metabolism, Inborn Errors, Mutation, Neonatal Screening, Odds Ratio